NO20000151L - Nitrogenoksid inhiberer rhinovirus infeksjon - Google Patents
Nitrogenoksid inhiberer rhinovirus infeksjonInfo
- Publication number
- NO20000151L NO20000151L NO20000151A NO20000151A NO20000151L NO 20000151 L NO20000151 L NO 20000151L NO 20000151 A NO20000151 A NO 20000151A NO 20000151 A NO20000151 A NO 20000151A NO 20000151 L NO20000151 L NO 20000151L
- Authority
- NO
- Norway
- Prior art keywords
- nitric oxide
- rhinovirus infection
- oxide inhibits
- inhibits rhinovirus
- inhibit
- Prior art date
Links
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 title abstract 10
- 206010061494 Rhinovirus infection Diseases 0.000 title abstract 3
- 102000004127 Cytokines Human genes 0.000 abstract 2
- 108090000695 Cytokines Proteins 0.000 abstract 2
- 230000015572 biosynthetic process Effects 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 238000003786 synthesis reaction Methods 0.000 abstract 2
- 238000011065 in-situ storage Methods 0.000 abstract 1
- 230000000770 proinflammatory effect Effects 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
- 230000029812 viral genome replication Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/15—Oximes (>C=N—O—); Hydrazines (>N—N<); Hydrazones (>N—N=) ; Imines (C—N=C)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pulmonology (AREA)
- Molecular Biology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Nitrogenoksidgenererende forbindelser eller forbindelser som induserer in situ syntese av nitrogenoksid kan bli benyttet for å inhibere rhinovirusinfeksjon. Nitrogenoksid cr istand til å inhibere både viral replikasjon, såvel som syntesen av cytokiner, spesielt de pro-inflammatoriske cytokinene. Følgelig kan symptomene på rhinovirusinfeksjoner bedres ved behandlinger som oker nitrogenoksid i luftveiene.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US5230797P | 1997-07-11 | 1997-07-11 | |
PCT/US1998/014466 WO1999002148A1 (en) | 1997-07-11 | 1998-07-10 | Nitric oxide inhibits rhinovirus infection |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20000151D0 NO20000151D0 (no) | 2000-01-11 |
NO20000151L true NO20000151L (no) | 2000-03-09 |
Family
ID=21976738
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20000151A NO20000151L (no) | 1997-07-11 | 2000-01-11 | Nitrogenoksid inhiberer rhinovirus infeksjon |
Country Status (14)
Country | Link |
---|---|
US (1) | US6277891B1 (no) |
EP (1) | EP1011657A1 (no) |
JP (1) | JP2001509481A (no) |
KR (1) | KR20010021749A (no) |
CN (1) | CN1277552A (no) |
AU (1) | AU8399098A (no) |
BR (1) | BR9811473A (no) |
CA (1) | CA2303430A1 (no) |
CZ (1) | CZ200092A3 (no) |
HU (1) | HUP0002859A2 (no) |
ID (1) | ID23780A (no) |
NO (1) | NO20000151L (no) |
TR (1) | TR200000157T2 (no) |
WO (1) | WO1999002148A1 (no) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR030753A1 (es) * | 2000-09-25 | 2003-09-03 | Smithkline Beecham Corp | Uso de moduladores-proteina de il-8, groalfa, grobeta, grogamma, nap-2, y ena-78, para tratar infecciones viricas |
GB0125222D0 (en) * | 2001-10-19 | 2001-12-12 | Barts & London Nhs Trust | Composition for the treatment of microbial infections |
DE10303196A1 (de) * | 2003-01-28 | 2004-08-12 | Märtz, Hans Helmut | Verwendung von Erzeugnissen, Stoffen oder Stoffgemischen, aus welchen im menschlichen oder tierischen Körper Stickoxid (Formel: NO) entsteht, zur Behandlung oder Prophylaxe von Infektionskrankheiten des menschlichen oder tierischen Körpers |
SE0300971D0 (sv) * | 2003-04-03 | 2003-04-03 | Aga Ab | Nitric oxide in treatment of inflammation |
DE602004008927T2 (de) * | 2003-07-09 | 2008-06-05 | The Government Of The United States Of America As Represented By The Secretary, Department Of Health And Human Services | Verwendung von nitritsalzen zur behandlung von kardiovaskulären erkrankungen |
US8252591B2 (en) | 2004-05-07 | 2012-08-28 | Whitehead Institute For Biomedical Research | Hormone responsive tissue culture system and uses thereof |
US7362274B1 (en) * | 2004-07-09 | 2008-04-22 | Huan-Cheng Lien | Coupled feed-in butterfly shaped left/right hand circularly polarized microstrip antenna |
US8557300B2 (en) | 2005-05-19 | 2013-10-15 | University Of Cincinnati | Methods for treating bacterial respiratory tract infections in an individual using acidified nitrite |
GB0607402D0 (en) * | 2006-04-12 | 2006-05-24 | Barts & London Nhs Trust | Therapeutic composition and use |
EP2188367A4 (en) | 2007-08-10 | 2010-10-27 | Whitehead Biomedical Inst | HORMONE REACTIVE TISSUE CULTURE SYSTEM, AND USES THEREOF |
AU2008345034A1 (en) * | 2007-12-27 | 2009-07-09 | Aires Pharmaceuticals, Inc. | Aerosolized nitrite and nitric oxide - donating compounds and uses thereof |
WO2009116944A1 (en) * | 2008-03-20 | 2009-09-24 | Krister Tano | Use of a substance for manufacturing of a medicament for treatment of common cold |
WO2019005901A1 (en) * | 2017-06-27 | 2019-01-03 | Ohio State Innovation Foundation | NUCLEOTIDE THERAPY FOR ASTHMA |
CN109432122A (zh) * | 2018-11-19 | 2019-03-08 | 罗辉 | No或no供体在制备预防和/或治疗皮肤疾病或黏膜疾病药物中的应用及药物组合物 |
CN109846113A (zh) * | 2018-11-29 | 2019-06-07 | 南京诺全生物医疗科技有限公司 | 一种可自提供一氧化氮的口鼻卫生用品 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5455279A (en) * | 1991-04-19 | 1995-10-03 | The Children's Medical Center Corporation | Regimen method of mediating neuronal damage using nitroglycerine |
-
1998
- 1998-07-10 WO PCT/US1998/014466 patent/WO1999002148A1/en not_active Application Discontinuation
- 1998-07-10 JP JP2000501743A patent/JP2001509481A/ja active Pending
- 1998-07-10 CN CN98810536A patent/CN1277552A/zh active Pending
- 1998-07-10 US US09/113,310 patent/US6277891B1/en not_active Expired - Fee Related
- 1998-07-10 BR BR9811473-5A patent/BR9811473A/pt not_active Application Discontinuation
- 1998-07-10 KR KR1020007000312A patent/KR20010021749A/ko not_active Application Discontinuation
- 1998-07-10 CZ CZ200092A patent/CZ200092A3/cs unknown
- 1998-07-10 AU AU83990/98A patent/AU8399098A/en not_active Abandoned
- 1998-07-10 EP EP98934479A patent/EP1011657A1/en not_active Withdrawn
- 1998-07-10 CA CA002303430A patent/CA2303430A1/en not_active Abandoned
- 1998-07-10 HU HU0002859A patent/HUP0002859A2/hu unknown
- 1998-07-10 ID IDW20000272A patent/ID23780A/id unknown
- 1998-07-10 TR TR2000/00157T patent/TR200000157T2/xx unknown
-
2000
- 2000-01-11 NO NO20000151A patent/NO20000151L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
NO20000151D0 (no) | 2000-01-11 |
BR9811473A (pt) | 2001-12-26 |
CN1277552A (zh) | 2000-12-20 |
TR200000157T2 (tr) | 2001-06-21 |
AU8399098A (en) | 1999-02-08 |
EP1011657A1 (en) | 2000-06-28 |
US6277891B1 (en) | 2001-08-21 |
CZ200092A3 (en) | 2001-05-16 |
JP2001509481A (ja) | 2001-07-24 |
KR20010021749A (ko) | 2001-03-15 |
ID23780A (id) | 2000-05-11 |
HUP0002859A2 (hu) | 2001-01-29 |
WO1999002148A1 (en) | 1999-01-21 |
CA2303430A1 (en) | 1999-01-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20000151L (no) | Nitrogenoksid inhiberer rhinovirus infeksjon | |
DK66493D0 (da) | Praeparater, isaer til brug ved behandling af inflammatoriske tarmsygdomme eller til at opnaa forbedret saarheling | |
MY138860A (en) | Hiv protease inhibitors. | |
EA200300810A1 (ru) | Вирус, вызывающий заболевание дыхательных путей у восприимчивых млекопитающих | |
TR200201048T2 (tr) | Soğuk algınlığı ve gribi andıran semptomların önlenmesi ve tedavisi için bileşimler | |
MY141594A (en) | 3'-PRODRUGS OF 2'-DEOXY-ß-L-NUCLEOSIDES | |
NO985821L (no) | Substituerte syklopentanforbindelser som er nyttige som neuraminidaseinhibitorer | |
DE69430232D1 (de) | Hemmung der Symptome des prämenstruellen Synchroms/dysphorische Erkrankungen der späten lutealen Phase | |
ES2165269A1 (es) | Derivados de alfa-cetoamidas. | |
ES2123156T3 (es) | Compuestos y procedimientos de inhibicion de hiv y virus semejantes. | |
DK1089744T3 (da) | Neurobeskyttende præparat til forebyggelse og/eller behandling af nervøse og adfærdsmæssige ændringer på grund af angsttilstande eller depression omfattende acetyl-L-carnitin og hypericin | |
ES2122015T3 (es) | Uso de urodilatina en enfermedades pulmonares y bronquiales. | |
ATE451934T1 (de) | Pharmazeutische zusammensetzung zur behandlung von rhinitiden | |
DE60036862D1 (de) | Synergistische hemmung von viralreplikation durch langkettigen kohlenwasserstoffe und nucleosid-analoge | |
SE0004101D0 (sv) | New use | |
TR200200246T2 (tr) | Nezle ve grip benzeri hastalıklar ile ilişkilendirilen semptomlardan korunma ve bunların tedavisi ile ilgili bileşim. | |
AP2001002181A0 (en) | Use of 17-ketosteroid compounds and derivatives, metabolites and precursors thereof in the treatment of hepatitis C virus and other toga viruses. | |
PT859613E (pt) | Utilizacao de flupirtina para a profilaxia e o tratamento de doencas associadas a uma alteracao do sistema celular hematopoietico | |
BG106748A (en) | Method and compositions for treating pulmonary diseases | |
AR125121A1 (es) | Actividad antiviral de inhibidores de vps34 | |
DK0576506T3 (da) | Anvendelse af benzimidazol-anthelmintikum ved behandling af mikrosporidial-infektioner | |
PT1091933E (pt) | Beta-dicetonas e sua utilizacao | |
ES2061053T3 (es) | Extractos de la planta acantospermum hispidum. | |
NO924806D0 (no) | Etanoladdukter av 6-sulfonylsubstituerte 3-hydroksykromaner og deres anvendelse som inhalasjonsmiddel ved sykdommer | |
DE59909855D1 (de) | Wirkstoff enthaltende orale oder mucosale zubereitung mit steuerbarer wirkstofffreisetzung und ihre verwendung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |